The KanaVape trial: what's at stake?
Next Monday sees the trial in Marseille of KanaVape, the first CBD-based electronic cigarette marketed in France in 2014.
Revolutionary at the time, the product was accused of being presented as a drug. The French Ministry of Health pushed hard to prohibit all marketing of the product in France, and to prosecute the two founders of KanaVape, Antonin Cohen and Sébastien Béguerie.
Antonin and Sébastien are not exactly strangers. One is now at the helm of Harmony, the recently launched featured on the front page of Le Parisien, the other markets cannabinoid test kits and CBD products under the brand name Alpha-Cat and is the co-founder of UFCM and co-organizer of the UFCM-I-Care conference in Strasbourg on the use of cannabinoids in medicine.
Both know their stuff, and have paved the way for all CBD e-liquids marketed in France today. So what will come out of this trial, even though the French Ministry of Health asserted this week in Le Parisien that these products are legal? We can't really answer that, or predict the outcome. But it goes without saying that we'll be following it closely.
Deliberation is scheduled for early 2018.
-
Business2 weeks ago
The legal cannabis market in New York exceeds 4 billion $ in revenue
-
Cannabis in France3 weeks ago
Which countries legalized medical cannabis before France?
-
Business3 weeks ago
South Korea is preparing to begin local production of medical cannabis to meet rising demand
-
Cannabis in Thailand3 weeks ago
From the boom in dispensaries to a purely medical approach: Thailand is revising its cannabis policy
-
Cannabis and driving3 weeks ago
Medical Cannabis and Driving: New South Wales Ends Automatic Penalties for THC
-
Cannabis in Argentina4 weeks ago
Argentina Opens Its Market to Hemp Flowers Containing 1% of THC
-
Autism3 weeks ago
Autism and Cannabis: Results from the First Placebo-Controlled Trial of NTI164
-
Cannabis in France2 weeks ago
France’s Drug Policy Chief Defends Cannabis Prohibition... and Runs Into the Facts


You must be logged in to post a comment Login